|

Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer

RECRUITINGSponsored by Charite University, Berlin, Germany
Actively Recruiting
SponsorCharite University, Berlin, Germany
Started2016-03-01
Est. completion2030-03-01
Eligibility
Age18 Years+
View on ClinicalTrials.gov →

NCT05926284

Summary

Prospective observational study of a precision medicine approach in patients with advanced cancer. In this registrational study, patients with advanced cancer undergoing extensive molecular sequencing within the precision oncology program of Charité University Medicine, Berlin will be registered and followed to assess the efficacy of the program and assess the clinical relevance and frequency of molecular alterations, individualized therapies and novel molecular analysis tools.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* advanced cancer
* ability to give written informed consent
* performance status allows initiation of a potential targeted treatment after molecular analysis
* molecular analysis has been done or planned

Exclusion Criteria:

\- unable to give written informed consent

Conditions1

Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.